TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD
oleh: Ulf Mueller-Ladner, Hendrik Schulze-Koops, Tim Schmeiser, Hanns-Martin Lorenz, Christof Specker, Reinhard E Voll, Bimba F Hoyer, Jutta Richter, Alexander Pfeil, Rebecca Hasseli, Andreas Krause, Anne Constanze Regierer, Martin Schäfer
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.